However, the emergence of retatrutide has introduced a "ceiling-breaking" potential that is difficult to ignore
The proportional hazards assumptions were tested using the generalized Schoenfeld approach [47]
Online providers offered compounded GLP-1 drugs to individuals at a discounted price when the medications were first approved and high demand created shortages, but the FDA earlier this year deemed the shortages were over and banned most compounded sales of the drugs
These temporary setbacks, while frustrating, resolve with appropriate management
Seek urgent medical attention (call NHS 111 or 999 for severe symptoms) if you experience: Severe, persistent abdominal pain, especially in the upper right quadrant (potential pancreatitis or gallbladder disease) Yellowing of the skin or eyes (jaundice) Signs of dehydration or significantly reduced urine output Symptoms of hypoglycaemia (particularly if you're taking insulin or sulfonylureas for diabetes) Allergic reactions (rash, swelling, difficulty breathing) Visual changes or severe headaches (especially if you have diabetes with pre-existing retinopathy) You should also discuss with your healthcare provider if cold sensitivity significantly impacts your quality of life, even without other concerning symptoms
Following up on my initial post about GHK-Cu injections, I wanted to dive deeper into why I chose this path and what I've learned along the way